Summary & Overview

CPT 99602: Home Infusion or Specialty Drug Administration, Additional Hour

CPT code 99602 represents an additional hour of a clinician visit to a patient’s home for infusion therapy or administration of a specialty drug after the initial two-hour visit. This code matters nationally as home-based infusion and specialty drug administration grow, shifting care from outpatient facilities to the home and creating distinct billing and resource considerations tied to time-based services.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical service captured by the code, which payers commonly reimburse or recognize the code, typical sites of service, and commonly associated billing modifiers. The publication also summarizes benchmark reimbursement patterns, documentation and coding considerations specific to time-based home infusion services, and relevant policy updates affecting coverage and payment pathways for home-administered specialty therapies.

This national overview is intended for coding professionals, billing managers, and clinical administrators seeking a clear reference on how CPT code 99602 is used, what clinical scenarios it describes, and which major payers to consider when aligning clinical workflows and claims processes.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare99602CPThome-infusionspecialty-drug-administrationtime-based-billinghome-healthinfusion-therapyprofessional-services

Billing Code Overview

CPT code 99602 describes a provider visit to a patient in the home to provide an infusion or to administer a specialty drug. This code is used for each additional hour of a home infusion or administration visit after the first two hours.

Service type: Home infusion or specialty drug administration visit (additional hour)
Typical site of service: Patient home

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A home infusion nurse from a home health agency visits a patient at their residence to administer a specialty infusion therapy for a chronic condition. Typical patients include those receiving intravenous biologic agents for rheumatoid arthritis, subcutaneous or intravenous immunoglobulin for primary immunodeficiency, or chemotherapy-adjunct biologics where outpatient infusion center access is limited. The clinical workflow begins with an order from the prescribing physician, verification of medication and dose by pharmacy, scheduling of a home visit, and travel to the patients home. The initial two hours of the visit (setup, assessment, infusion initiation, monitoring, and documentation) are billed under the base home infusion visit. When the encounter extends beyond two hours due to prolonged infusion time, complex administration, patient comorbidities, or additional nursing procedures, each additional hour is reported using 99602. The nurse documents start and stop times, clinical assessments, medication lot numbers, infusion pump settings, patient tolerance, and any interventions. Communication with the ordering provider is documented for dose adjustments or adverse events. Typical sites of service are the patients private residence or long-term care facility when billed as a home visit. Common payors involved include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare for home infusion services under applicable benefit coverage rules.

Coding Specifications

Modifier	Description	When to Use
`22`

Taxonomy Code	Specialty	Notes
`163W00000X`	Home Health Care	Home infusion nursing services are commonly delivered by this specialty.
`163WI0200X`	Infusion Therapy	Clinicians specializing in infusion therapy provide medication administration and monitoring.
`207P00000X`	Internal Medicine	Ordering physicians for chronic infusion therapies often include internists.
`207R00000X`	Rheumatology	Rheumatologists frequently prescribe biologic infusions administered at home.
`208D00000X`	Allergy & Immunology	Specialists ordering immunoglobulin infusions for immunodeficiency or autoimmune conditions.

ICD-10 Code	Description	Clinical Relevance
`C80.1`	Metastatic cancer with unspecified primary	Patients receiving palliative infusions or supportive biologic agents at home may have metastatic disease requiring home administration.
`M05.79`	Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement	Rheumatology patients on biologic infusion therapies commonly receive home infusion services.
`D80.9`	Immunodeficiency, unspecified	Patients with primary immunodeficiency may receive immunoglobulin infusions at home.
`G35`	Multiple sclerosis	Some disease-modifying therapies are administered via infusion or specialty drug delivery in the home setting.
`Z51.11`	Encounter for antineoplastic chemotherapy	Indicates the reason for infusion visits when chemotherapy or related supportive agents are administered at home.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99601`	Home visit for administration of infusion or injection of cancer chemotherapeutic agent; initial 2 hours	Often billed as the base visit for the first two hours; `99602` is used for each additional hour beyond this base time.
`96365`	Intravenous infusion, therapeutic, prophylactic, or diagnostic; initial, up to 1 hour	May be used for shorter outpatient/office infusion services prior to arranging home infusion or for concurrent clinic infusions.
`96366`	Intravenous infusion, each additional hour (List separately in addition to code for primary infusion)	Analogous in concept for hour-based reporting in other infusion settings; relates to time-based billing for prolonged infusions.
`36561`	Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump, age 5 years or older	May be performed prior to establishing long-term home infusion access when needed.
`99024`	Postoperative follow-up visit, included in global service; not separately billable when provided	Documentation reference for follow-up communication; not typically billed separately with home infusion visits unless payer allows.

OpenPayer